President Trump’s efforts to undermine the health law have widened the gap between those who get government aid and those who don’t, deepening resentments.
The Independent Payment Advisory Board was supposed to make it easier for Congress to control Medicare spending. But Congress never loved it. Now it's gone.
Mr. Azar, a former drug company executive, immediately confronts two huge challenges: how to rein in drug prices and how to administer the Affordable Care Act.